These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24444521)

  • 1. [Contribution of the kidney to glucose homeostasis].
    Segura J; Ruilope LM
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():26-30. PubMed ID: 24444521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaching to DM2 through sodium-glucose cotransporter-2: does it make sense?
    Segura J
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():22-25. PubMed ID: 28760221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment].
    Girard J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
    Gallo LA; Wright EM; Vallon V
    Diab Vasc Dis Res; 2015 Mar; 12(2):78-89. PubMed ID: 25616707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
    Ghezzi C; Loo DDF; Wright EM
    Diabetologia; 2018 Oct; 61(10):2087-2097. PubMed ID: 30132032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
    Vallon V; Thomson SC
    Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products as Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors.
    Blaschek W
    Planta Med; 2017 Aug; 83(12-13):985-993. PubMed ID: 28395363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose handling by the kidney.
    Mather A; Pollock C
    Kidney Int Suppl; 2011 Mar; (120):S1-6. PubMed ID: 21358696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.
    Wilding JP
    Metabolism; 2014 Oct; 63(10):1228-37. PubMed ID: 25104103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].
    Pérez López G; González Albarrán O; Cano Megías M
    Nefrologia; 2010; 30(6):618-25. PubMed ID: 21113210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial renal glycosuria and modifications of glucose renal excretion.
    Prié D
    Diabetes Metab; 2014 Dec; 40(6 Suppl 1):S12-6. PubMed ID: 25554066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.
    Gerich JE
    Diabet Med; 2010 Feb; 27(2):136-42. PubMed ID: 20546255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contributions of SGLT-2 and new drugs under investigation].
    Mediavilla Bravo JJ
    Semergen; 2014 Jul; 40 Suppl 2():34-40. PubMed ID: 25311718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal glucose reabsorption inhibitors to treat diabetes.
    Bailey CJ
    Trends Pharmacol Sci; 2011 Feb; 32(2):63-71. PubMed ID: 21211857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects.
    Norton L; Shannon CE; Fourcaudot M; Hu C; Wang N; Ren W; Song J; Abdul-Ghani M; DeFronzo RA; Ren J; Jia W
    Diabetes Obes Metab; 2017 Sep; 19(9):1322-1326. PubMed ID: 28477418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.
    Solini A; Rossi C; Mazzanti CM; Proietti A; Koepsell H; Ferrannini E
    Diabetes Obes Metab; 2017 Sep; 19(9):1289-1294. PubMed ID: 28419670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.
    DeFronzo RA; Norton L; Abdul-Ghani M
    Nat Rev Nephrol; 2017 Jan; 13(1):11-26. PubMed ID: 27941935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal glucose metabolism in normal physiological conditions and in diabetes.
    Alsahli M; Gerich JE
    Diabetes Res Clin Pract; 2017 Nov; 133():1-9. PubMed ID: 28866383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
    Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.